Cargando…
Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
Background: Transgender people using hormone treatment require lifelong medical care. Although cross-sex hormone treatment (CSHT) is usually considered safe, serious adverse events may occur. Here we report a case of deep vein thrombosis associated with estradiol treatment in an otherwise healthy yo...
Autores principales: | Oguz, Seda Hanife, Buyukasik, Yahya, Yildiz, Bulent O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089771/ http://dx.doi.org/10.1210/jendso/bvab048.1611 |
Ejemplares similares
-
Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021) -
Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021) -
SAT360 Ovarian Vein Sampling in a Pre-menopausal Woman with Hyperandrogenism: Characterization of Hormonal Profiles
por: Hu, Tina Y, et al.
Publicado: (2023) -
LBSAT133 Dilemmas In The Diagnosis Of Osteoporosis In Transgender Population
por: Vasanthaakumar, Vijaykiran P, et al.
Publicado: (2022) -
MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)